Business & Finance

The Rudd Report updates research on AMDL's activities in the China pharmaceutical market

Published in Health Insurance Week, December 31st, 2006

AMDL, Inc. (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced that The Rudd Report has updated its research on AMDL, highlighting the opportunity AMDL has in the Chinese pharmaceutical market.

The report said that China is developing a new and massive middle class, whose spending power will redefine the Chinese market. "These working consumers, once the country's poorest, will steadily climb the income ladder, with the result that hundreds of millions of households will enter the country's middle class. While some companies are already focusing on this evolution, many others have yet to broaden their...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week

Source: Health Insurance Week (2006-12-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry